Keyphrases
6-minute Walk Distance (6MWD)
5%
Angiostatic
12%
Binding Protein
18%
Cardiac Dysfunction
6%
Caregiver-child Interaction
6%
CD56 Expression
6%
Children with Down Syndrome
6%
Clinical Outcomes
19%
Clinical Phenotype
12%
Clinical Worsening
6%
Congenital Diaphragmatic Hernia
12%
Congenital Heart
6%
Disease Course
12%
Disease Severity
22%
Disease Survival
13%
Endostatin
26%
Fetal Endoscopic Tracheal Occlusion
6%
Growth Factor Binding
18%
Health-related Quality of Life
6%
Hepatocyte Growth Factor
6%
Hypertension Disease
18%
Initial Treatment
6%
Insulin-like
18%
Insulin-like Growth Factor 2 mRNA-binding Protein 2 (IGF2BP2)
7%
Insulin-like Growth factor-1
5%
Interleukin-6
18%
Interleukin-6 Levels
7%
Johns Hopkins
6%
Left-sided Heart Failure
6%
Mortality Prediction
6%
Multicenter Trial
6%
Multidisciplinary Clinic
6%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
8%
Pediatric
9%
Pediatric Congenital
6%
Pediatric Hypertension
24%
Perinatology
6%
Plasma Cell Myeloma
6%
Preterm Infants
6%
Prognostic Biomarker
6%
Proteomics
6%
Pulmonary Arterial Hypertension
46%
Pulmonary Artery Smooth muscle Cells (PASMCs)
6%
Pulmonary Hypertension
45%
Pulmonary Vascular Remodeling
7%
Risk Factors
7%
Soluble Suppression of Tumorigenicity 2 (sST2)
8%
Survival Prediction
6%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
7%
Medicine and Dentistry
Amino Terminal Sequence
9%
Biological Marker
36%
Brain Natriuretic Peptide
11%
Brugada Syndrome
6%
Carcinogenicity
13%
Cohort Effect
6%
Congenital Diaphragm Hernia
12%
Congenital Malformation
6%
Disease
11%
Disease Course
13%
Disease Severity
22%
Endostatin
25%
Extracorporeal Membrane Oxygenation
6%
Galectin 3
6%
Hazard Ratio
5%
Heart Failure
13%
Hemodynamic
8%
Hepatoma Derived Growth Factor
12%
Intensive Care Unit
6%
Interleukin 6
18%
Molecular Diagnosis
6%
Pediatrics
51%
Perinatology
6%
Persistent Truncus Arteriosus
16%
Polycyclic Aromatic Hydrocarbon
16%
Prevalence
6%
Pulmonary Hypertension
100%
Pulmonary Valve Replacement
6%
Quality of Life
7%
Somatomedin Binding Protein 2
12%
Tetralogy of Fallot
6%
Vascular Remodeling
6%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
36%
Brain Natriuretic Peptide
12%
Carcinogenicity
16%
Congenital Diaphragm Hernia
6%
Congenital Heart Disease
6%
Disease
5%
Disease Course
7%
Disease Severity
13%
Down Syndrome
6%
Endostatin
9%
Galectin 3
9%
Heart Failure
13%
Hepatoma Derived Growth Factor
6%
Interleukin 6
12%
Polycyclic Aromatic Hydrocarbon
13%
Pulmonary Hypertension
50%
Somatomedin Binding Protein 2
6%
